These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3708624)

  • 1. Severe hyponatremia following simultaneous administration of aminoglutethimide and diuretics.
    Bork E; Hansen M
    Cancer Treat Rep; 1986 May; 70(5):689-90. PubMed ID: 3708624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day].
    Bonneterre J; Coppens H; Mauriac L; Rouesse J; Fargeot P; Metz R; Armand JP; Mathieu A; Tubiana M; Cappelaere P
    Acta Clin Belg Suppl; 1986; 11():41-8. PubMed ID: 3521171
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies with aminoglutethimide in advanced breast carcinoma.
    Harvey HA; Lipton A; Santen RJ
    Acta Clin Belg Suppl; 1986; 11():29-40. PubMed ID: 3459321
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of aminoglutethimide and hydrocortisone as a "medical adrenalectomy" for treatment of breast carcinoma.
    Santen RJ; Lipton A; Harvey H; Wells SA
    Prog Clin Cancer; 1982; 8():245-65. PubMed ID: 7156404
    [No Abstract]   [Full Text] [Related]  

  • 5. A call for caution in the use of aminoglutethimide: negative interactions with dexamethasone and beta blocker treatment.
    Halpern J; Catane R; Baerwald H
    J Med; 1984; 15(1):59-63. PubMed ID: 6149250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer.
    Harris AL; Cantwell BM; Sainsbury JR; Needham G; Evans RG; Dawes PJ; Wilson R; Farndon J
    Breast Cancer Res Treat; 1986; 7 Suppl():S41-4. PubMed ID: 3742063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical adrenalectomy with aminoglutethimide-cortisol in the treatment of metastatic breast carcinoma.
    Paridaens R; Van Haelen C; Heuson JC
    Eur J Cancer (1965); 1980; Suppl 1():103-6. PubMed ID: 7318860
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombocytopenia after combination therapy with aminoglutethimide and tamoxifen: which drug is to blame?
    Ragaz J; Buskard N; Manji M
    Cancer Treat Rep; 1984; 68(7-8):1015-6. PubMed ID: 6744333
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
    Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
    Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aminoglutethimide-induced dyslipemia. Clinical study].
    Bonneterre J; Nguyen M; Hecquet B; Fournier C; Demaille A
    Bull Cancer; 1985; 72(2):99-103. PubMed ID: 3924146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aminoglutethimide plus hydrocortisone on the genital tract of postmenopausal women with advanced breast cancer. A clinical and cytologic survey.
    Budel VM; Paridaens RJ; Spetschinsky A; Heuson JC; Gompel C
    Anticancer Res; 1986; 6(4):709-12. PubMed ID: 3752949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer.
    Nagel GA; Wander HE; Blossey HC
    Cancer Res; 1982 Aug; 42(8 Suppl):3442s-3444s. PubMed ID: 6123383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE; Bird CE; Mackie KW
    Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to induce severe electrolyte disturbances in the elderly?
    Hörl WH
    Wien Klin Wochenschr; 2002 Nov; 114(21-22):885-6. PubMed ID: 12528317
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
    Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyponatremia caused by thiazide diuretics: be aware of drug combinations which enhance this effect].
    Wollersheim H
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2109-10; author reply 2110. PubMed ID: 12448970
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
    Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
    Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could this be a drug side effect?
    Phillips PJ; Tallis GA; Popplewell PY
    Aust Fam Physician; 1999 Mar; 28(3):269-70. PubMed ID: 10098309
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe diuretic-induced hyponatremia in the elderly. A series of eight patients.
    Ashouri OS
    Arch Intern Med; 1986 Jul; 146(7):1355-7. PubMed ID: 3718133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia due to an additive effect of carbamazepine and thiazide diuretics.
    Ranta A; Wooten GF
    Epilepsia; 2004 Jul; 45(7):879. PubMed ID: 15230718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.